Article
Myelodysplastic Syndrome: Diagnosis and Screening
29 Jun 2022
Abstract excerpt
Myelodysplastic syndromes (MDS) are heterogeneous groups of clonal myeloid disorders characterized by unexplained persistent peripheral blood (PB) cytopenia(s) of one or more of the hematopoietic lineages, or bone marrow (BM) morphologic dysplasia in hematopoietic cells, recurrent genetic abnormalities, and an increased risk of progression to acute myeloid leukemia (AML). In the past several years, diagnostic,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
